Advertisement
Advertisement

PDSB

PDSB logo

PDS Biotechnology Corporation Common Stock

0.84
USD
Sponsored
-0.06
-6.99%
Jan 29, 11:25 UTC -5
Open

PDSB Earnings Reports

Positive Surprise Ratio

PDSB beat 25 of 36 last estimates.

69%

Next Report

Date of Next Report
Mar 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.19
Implied change from Q3 25 (Revenue/ EPS)
--
/
--
Implied change from Q4 24 (Revenue/ EPS)
--
/
-9.52%

PDS Biotechnology Corporation Common Stock earnings per share and revenue

On Nov 13, 2025, PDSB reported earnings of -0.19 USD per share (EPS) for Q3 25, beating the estimate of -0.21 USD, resulting in a 12.68% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -12.33% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.19 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, PDS Biotechnology Corporation Common Stock reported EPS of -$0.19, beating estimates by 12.68%, and revenue of $0.00, 0% as expectations.
The stock price moved down -12.33%, changed from $0.96 before the earnings release to $0.84 the day after.
The next earning report is scheduled for Mar 25, 2026.
Based on 4 analysts, PDS Biotechnology Corporation Common Stock is expected to report EPS of -$0.19 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement